文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

肛直肠壁剂量表面图定位水凝胶直肠间隔物在前列腺癌放疗中的剂量学获益

Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy.
PubMed 文献 · Clin Transl Radiat Oncol · 2018-11-03

该研究对26例前列腺癌患者的肛直肠壁生成剂量表面图,比较植入与未植入直肠间隔物的调强放疗计划的空间剂量差异,并用空间与非空间NTCP模型关联晚期胃肠毒性。结果显示在高剂量区,植入间隔物组的横向范围、纵向范围和连续DSH显著更低,空间NTCP模型预测2级晚期直肠出血和主观括约肌控制的中位NTCP显著下降(p=0.01)。

要点

  • 植入直肠间隔物在高剂量区显著降低肛直肠壁的横向范围、纵向范围和连续DSH。
  • 空间NTCP模型预测植入间隔物后2级晚期直肠出血和主观括约肌控制的中位NTCP显著下降(p=0.01)。
  • 作者认为空间NTCP模型可改善当前临床治疗计划的剂量约束。

核心结论

  • 局部剂量效应预测因植入直肠间隔物而显著降低。
  • 空间NTCP模型预测2级晚期直肠出血和主观括约肌控制显著下降。
  • 作者认为可改善当前临床治疗计划的剂量约束。

研究设计与样本

  • 对26例患者的肛直肠壁生成剂量表面图。
  • 比较IMRT+IRS与IMRT-IRS计划的空间剂量差异。
  • 使用空间与非空间NTCP模型评估预测并发症率。

主要发现

  • 在高剂量水平,IMRT+IRS的横向范围、纵向范围和连续DSH显著低于IMRT-IRS。
  • 最大显著差异见于剂量>50 Gy时的连续DSH,其次为剂量>57 Gy时的横向范围以及前后和上下方向的纵向范围。
  • 使用直肠间隔物时,预测的中位直肠和肛门NTCP(分别为2级晚期直肠出血和主观括约肌控制)显著下降(p=0.01)。

关键数值与推荐

  • 连续DSH在剂量>50 Gy时差异最大且显著。
  • 横向范围在剂量>57 Gy时差异显著。
  • 纵向范围在前后和上下方向差异显著。
  • 中位直肠和肛门NTCP下降的p=0.01。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To evaluate spatial differences in dose distributions of the ano-rectal wall (ARW) using dose-surface maps (DSMs) between prostate cancer patients receiving intensity-modulated radiation therapy with and without implantable rectum spacer (IMRT+IRS; IMRT-IRS, respectively), and to correlate this with late gastro-intestinal (GI) toxicities using validated spatial and non-spatial normal-tissue complication probability (NTCP) models. MATERIALS AND METHODS: For 26 patients DSMs of the ARW were generated. From the DSMs various shape-based dose measures were calculated at different dose levels: lateral extent, longitudinal extent, and eccentricity. The contiguity of the ARW dose distribution was assessed by the contiguous-DSH (cDSH). Predicted complication rates between IMRT+IRS and IMRT-IRS plans were assessed using a spatial NTCP model and compared against a non-spatial NTCP model. RESULTS: Dose surface maps are generated for prostate radiotherapy using an IRS. Lateral extent, longitudinal extent and cDSH were significantly lower in IMRT+IRS than for IMRT-IRS at high-dose levels. Largest significant differences were observed for cDSH at dose levels >50 Gy, followed by lateral extent at doses >57 Gy, and longitudinal extent in anterior and superior-inferior directions. Significant decreases (p = 0.01) in median rectal and anal NTCPs (respectively, Gr 2 late rectal bleeding and subjective sphincter control) were predicted when using an IRS. CONCLUSIONS: Local-dose effects are predicted to be significantly reduced by an IRS. The spatial NTCP model predicts a significant decrease in Gr 2 late rectal bleeding and subjective sphincter control. Dose constraints can be improved for current clinical treatment planning.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Vanneste BGL, Buettner F, Pinkawa M, et al. Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy. Clin Transl Radiat Oncol. 2018. PMID: 30456317. doi:10.1016/j.ctro.2018.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。